Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2020

MemberEmploymentResearch grantOther research supportSpeakers’ bureau/honorariaOwnership interestConsultant/advisory boardOther
Professional Practice Committee
Boris Draznin, MD, PhD (Chair)University of Colorado Denver, School of MedicineNoneNoneNoneNoneNoneeDoctate (unpaid professional education)
Vanita R. Aroda, MDBrigham and Women’s Hospital; Faculty, Harvard Medical SchoolApplied Therapeutics#, Premier/Fractyl#, Novo Nordisk#, Sanofi#NoneNoneMerck (spouse employee benefits), Janssen (spouse employee benefits)Applied Therapeutics#, Duke, Novo Nordisk#*, Pfizer, SanofiMerck Research Laboratories (spouse employee) 2017–2020 Janssen Pharmaceutical Companies of Johnson & Johnson (spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present)
George Bakris, MDUniversity of ChicagoBayer: principal investigator—clinical trial#NoneNoneNoneMerck, Relypsa/Vifor, KBP, Biosciences, Ionis, Alnylam, AstraZenecaSteering committee member of clinical outcome trials for Vascular Dynamics and Novo Nordisk
Gretchen Benson, RDN, LD, CDCESMinneapolis Heart Institute FoundationNoneNoneNoneNoneNoneNone
Florence M. Brown, MDJoslin Diabetes Center, Inc.NoneNoneNoneNoneNoneNone
RaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BCHCA HealthcareNoneNoneNoneNoneNoneNone
Jennifer Green, MDDuke University Medical CenterBoehringer Ingelheim*#, Merck#,
Sanofi Lexicon*#
NoneNoneNoneAstraZeneca, Boehringer Ingelheim*,
Novo Nordisk*,
Pfizer, Hawthorne Effect
Elbert Huang, MD, MPH, FACPUniversity of ChicagoNoneNoneNoneMerck, Pfizer—stockholderNoneMedical Research Analytics and Informatics Alliance—BOD
The Institute for Clinical and Economic Review—Midwest Comparative Effectiveness Public Advisory Council
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCESCleveland ClinicNoneNoneAbbott, Dexcom, Xeris Pharmaceuticals,
Novo Nordisk,
Companion Medical
NoneAssociation of Diabetes Care and Education Specialists, Eli Lilly, Insulet, LifeScanNone
Scott Kahan, MD, MPHGeorge Washington University, Milken Institute, National Center for Weight and WellnessNoneNoneNoneNoneVivus*, Gelesis, Pfizer(All without compensation)
The Obesity Society—BOD
American Board of Obesity Medicine—BOD
National Diabetes Education Program—author/editor
National Academy of Science/IOM—Committee on Obesity Solutions
Obesity Action Coalition—BOD
Obesity Treatment Foundation—BOD
Endocrine Society—Advocacy and Public Outreach Core Committee
True Health Initiative—BOD
Global Liver Institute/NASH Council—Advisory Board
Endocrine Today—Editorial Board
Medscape—Diabetes & Endocrinology Advisory Board
Medscape—Obesity Advisory Board
Strategies to Overcome and Prevent (STOP) Obesity Alliance
Christine Lee, MD, MSNational Institute of Diabetes and Digestive and Kidney DiseasesNoneNoneNoneNoneNoneNone
Jose Leon, MD, MPHNational Center for Health in Public HousingNoneNoneNoneNoneNoneNone
Sarah K. Lyons, MDBaylor College of Medicine/Texas Children’s HospitalNoneNoneNoneNoneNoneNone
Anne L. Peters, MDKeck School of Medicine of USCDexcom#, vTv Therapeutics#NoneNoneStock optionsAbbott Diabetes Care,
Bio-Rad, Eli Lilly, MannKind,
Merck, Novo Nordisk,
Medscape Endocrinology Advisory Board/video blogger*
Jane E.B. Reusch, MDUniversity of ColoradoNoneNoneNoneNoneMedtronic#None
Deborah Young-Hyman, PhD, CDCESBehavioral Health & Social Science Research, National Institutes of HealthNoneNoneNoneNoneNoneNone
American College of Cardiology Designated Representatives (Section 10 “Cardiovascular Disease and Risk Management”)
Sandeep Das, MD, MPH, FACCUniversity of Texas Southwestern Medical CenterNoneNoneAssociate EditorNoneNoneNone
Mikhail Kosiborod, MD, FACCSaint Luke’s Mid America Heart InstituteAstraZeneca#, Boehringer-Ingelheim#AstraZeneca#NoneNoneAmgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Eli Lilly, Janssen#, Merck Diabetes*, Novo Nordisk*#, Sanofi*, Vifor Pharma*#None
American Diabetes Association Staff
Mindy Saraco, MHAAmerican Diabetes AssociationNoneNoneNoneNoneNoneNone
Malaika I. Hill, MAAmerican Diabetes AssociationNoneNoneNoneNoneNoneNone
Matthew P. PetersenAmerican Diabetes AssociationNoneNoneNoneNoneNoneNone
Shamera Robinson, MPH, RDNAmerican Diabetes AssociationNoneNoneNoneNoneNoneNone
Jo Mandelson, MS, RDNAmerican Diabetes AssociationNoneNoneNoneNoneNoneNone
Robert A. Gabbay, MD, PhDAmerican Diabetes Association (Joslin Diabetes Center)NoneNoneNoneNoneOnduo*, Health Reveal, Form Health, Lark*, Vida Health*Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association
Kenneth P. Moritsugu, MD, MPHAmerican Diabetes Association, First Samurai Consulting, LLCNoneNoneNoneFirst Samurai Consulting, LLCNoneNone
  • BOD, board of directors; IOM, Institute of Medicine; NASH, nonalcoholic steatohepatitis.

  • * ≥$10,000 per year from company to individual.

  • # Grant or contract is to university or other employer. Kenneth P. Moritsugu, MD, MPH, worked as the Interim Chief Scientific and Medical Officer of the American Diabetes Association (ADA) until July 2020. Prior to joining ADA in July 2020, Robert Gabbay, MD, PhD, was employed by Joslin Diabetes Center.